Mind Medicine (MindMed) Inc., a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address
addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The company is headquartered in New York, New York. The company trades on NCM exchange. The company headquarter is located in New York, United States.
| Ticker | MNMD |
| Long Name | Mind Medicine (MindMed) Inc. |
| Short Name | Mind Medicine (MindMed) Inc. - |